(Q28192516)

12 December 2020

An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways

1 reference

12 December 2020

Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma

1 reference

12 December 2020

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

1 reference

12 December 2020

Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers

1 reference

12 December 2020

Metabolism and excretion of zafirlukast in dogs, rats, and mice

1 reference

12 December 2020

Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma

1 reference

12 December 2020

Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma

1 reference

12 December 2020

Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction

1 reference

12 December 2020

Pulmonary eosinophilia associated with montelukast

1 reference

12 December 2020

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

12 December 2020

Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma

1 reference

12 December 2020

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

12 December 2020

Comparison of zafirlukast (Accolate) absorption after oral and colonic administration in humans

1 reference

12 December 2020

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

1 reference

12 December 2020

The role and contribution of leukotrienes in asthma

1 reference

12 December 2020

Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials

1 reference

12 December 2020

Leukotriene-receptor antagonists

1 reference

12 December 2020

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

1 reference

12 December 2020

Asthma drug linked with Churg-Strauss syndrome

1 reference

12 December 2020

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

1 reference

12 December 2020

A drug interaction between zafirlukast and theophylline

1 reference

12 December 2020

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

1 reference

12 December 2020

A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy

1 reference

12 December 2020

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

12 December 2020

Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma

1 reference

12 December 2020

Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast

1 reference

12 December 2020

Churg-Strauss syndrome associated with zafirlukast

1 reference

12 December 2020

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.

1 reference

12 December 2020

Steroids and Churg-Strauss syndrome

1 reference

12 December 2020

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

12 December 2020

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction

1 reference

12 December 2020

Leukotrienes as a target in asthma therapy

1 reference

12 December 2020

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

12 December 2020

The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness

1 reference

12 December 2020

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

1 reference

12 December 2020

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge

1 reference

12 December 2020

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

1 reference

12 December 2020

Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal-phase high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

1 reference

12 December 2020

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

1 reference

12 December 2020

Churg-Strauss syndrome associated with zafirlukast.

1 reference

12 December 2020

Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness

1 reference

12 December 2020